Roche Holding AG
OTC
| Weiss Ratings | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price (Date) | -- | |||
| Valuation | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 306.35B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 11.65 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 802.00M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 91.97% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 41 61 688 88 80 | |||
| Address | -- | |||
| Website | www.roche.com | |||
| Country | Switzerland | |||
| Year Founded | 1896 | |||
| Profitability | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 31.40% | |||
| Profit Margin | 13.19% | |||
| Management Effectiveness | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 12.66% | |||
| Return on Equity | 26.17% | |||
| Income Statement | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 68.74B | |||
| Total Revenue (TTM) | 70.90B | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 53.02B | |||
| EBITDA (TTM) | 25.79B | |||
| EBIT (TTM) | 22.26B | |||
| Net Income (TTM) | 9.36B | |||
| Net Income Avl. to Common (TTM) | 9.36B | |||
| Total Revenue Growth (Q YOY) | 6.96% | |||
| Earnings Growth (Q YOY) | -47.64% | |||
| EPS Diluted (TTM) | 11.65 | |||
| EPS Diluted Growth (Q YOY) | -53.48% | |||
| Balance Sheet | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.13B | |||
| Cash Per Share (Q) | $23.85 | |||
| Total Current Assets (Q) | 44.18B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 39.90B | |||
| Current Ratio (Q) | 1.482 | |||
| Book Value Per Share (Q) | $44.07 | |||
| Total Assets (Q) | 112.34B | |||
| Total Current Liabilities (Q) | 29.82B | |||
| Total Debt (Q) | 40.15B | |||
| Total Liabilities (Q) | 72.44B | |||
| Total Common Equity (Q) | 35.06B | |||
| Cash Flow | - OTC | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -13.01B | |||
| Cash from Financing (TTM) | -7.70B | |||
| Net Change in Cash (TTM) | 1.85B | |||
| Levered Free Cash Flow (TTM) | 15.58B | |||
| Cash from Operations (TTM) | 22.88B | |||
